Skip to main content
Article thumbnail
Location of Repository

Role of Anticonvulsant and Antiepileptogenic Neurosteroids in the Pathophysiology and Treatment of Epilepsy

By Doodipala Samba Reddy

Abstract

This review highlights the role of major endogenous neurosteroids in seizure disorders and the promise of neurosteroid replacement therapy in epilepsy. Neurosteroids are endogenous modulators of seizure susceptibility. Neurosteroids such as allopregnanolone (3α-hydroxy-5α-pregnane-20-one) and allotetrahydrodeoxycorticosterone (3α,21-dihydroxy-5α-pregnan-20-one) are positive modulators of GABA-A receptors. Aside from peripheral tissues, neurosteroids are synthesized within the brain, mostly in principal neurons. Neurosteroids potentiate synaptic GABA-A receptor function and also activate δ-subunit-containing extrasynaptic GABA-A receptors that mediate tonic currents and thus may play an important role in neuronal network excitability and seizure susceptibility. Our studies over the past decade have shown that neurosteroids are broad-spectrum anticonvulsants and confer seizure protection in various animal models. They protect against seizures induced by GABA-A receptor antagonists, 6-Hz model, pilocarpine-induced limbic seizures, and seizures in kindled animals. Unlike benzodiazepines, tolerance does not occur to their actions during chronic administration. Our recent studies provide compelling evidence that neurosteroids may have antiepileptogenic properties. There is emerging evidence that endogenous neurosteroids may play a key role in the pathophysiology of catamenial epilepsy, stress–sensitive seizure conditions, temporal lobe epilepsy, and alcohol-withdrawal seizures. It is suggested that neurosteroid replacement with natural or synthetic neurosteroids may be useful in the treatment of epilepsy. Synthetic analogs of neurosteroids that are devoid of hormonal side effects show promise in the treatment of diverse seizure disorders. Agents that stimulate endogenous production of neurosteroids may also be useful for treatment of epilepsy

Topics: Endocrinology
Publisher: Frontiers Research Foundation
OAI identifier: oai:pubmedcentral.nih.gov:3356070
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (1989). Anticonvulsant profile of the progesterone metabolite 5α-pregnan-3α-ol-20-one.
    2. (2006). Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis.
    3. (2006). Endogenous neurosteroids modulate epileptogenesis in a model of temporal lobe epilepsy.
    4. (2005). Menstrual cycle worsening of epileptic seizures in women with symptomatic focal epilepsy.
    5. (2010). Neurosteroids and epilepsy.
    6. (2009). Neurosteroids and epileptogenesis in the pilocarpine model: evidence for a relationshipbetweenP450sccinduction and length of the latent period.
    7. (2003). Neurosteroids shift partial agonistactivationofGABA-Areceptor channels from low- to highefficacy gating patterns.
    8. (2011). Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons.
    9. (2000). Serum androgens return to normal after temporal lobe epilepsy surgery in men.
    10. (1981). Steroid hormones in the brain: several mechanisms?”
    11. The effects of inhibitors of GABAergic transmission and stress on brain and plasma allopregnanolone concentrations.
    12. (2002). The influence of subunit composition on the interaction of neurosteroids with GABAA receptors.
    13. (1996). Time-dependent changes in rat brain neuroactive steroid concentrations and GABAA receptor function after acute stress.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.